AU Patent
AU2001281970A1 — Arylethene-sulfonamides, their preparation and their use as endothelin antagonists
Assigned to Actelion Pharmaceuticals Ltd · Expires 2002-05-02 · 24y expired
What this patent protects
Patent listed against Opsumit.
Drugs covered by this patent
- Opsumit (MACITENTAN) · AstraZeneca
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.